PharmaReports: Technology
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
The technology channel relates to all things biotech. Reports describing, for example, advances in peptide, protein, genomics/proteomics and cell based sciences are included. This channel also focuses on novel drug delivery technologies and novel screening tools
Showing results 51 - 100 of 265
- Therapeutic Proteins
- The World Market for In Vitro Diagnostics, 2005
- Nanomedicine 2006-2011
- The Global Biotech Report 2006: The rise of the Biotech blockbusters
- Bioinformatics Report - The forecasts and future of the market 2006-2011
- Therapeutic Monoclonal Antibodies, 2006-2011
- World market for cancer vaccines 2007-2012
- Stem Cells - Business opportunities and forecasts
- Theranostics Report 2007-2012
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Tissue Engineering and Stem Cell Technology Report 2007
- Age Related Macular Degeneration Market Outlook to 2012
- The Global Rheumatoid Arthritis Market Forecasts to 2012
- Cardiac Rhythm Management Devices World Markets: Defibrillators, Pacemakers and Leads
- Pipeline Insight: Hematological Malignancies - Pursuit for the next blockbuster intensifies
- Early Toxicology: Markets and Approaches
- DNA Sequencing Equipment and Services Markets
- Pipeline and Commercial Insight: Influenza Vaccines - Pandemic threat revitalizes the sector
- Psoriasis - Anti-TNF's lead another indication
- Multiple Sclerosis - Disease-modifying efficacy and side effects guide treatment
- Melanoma - Lucrative commercial opportunities persist
- Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities
- Biosimilars: Benchmarking the key players
- Therapeutic Cancer Vaccines - A turbulent path from bench to bedside
- Gynecological Cancers - Niche opportunities in advanced disease
- Biosimilars: Regulatory Issues - Europe continues to make strides while the US lags behind
- Inflammatory Bowel Disease-Competition Increases for the Biologics
- Non-Small Cell Lung Cancer
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Colorectal Cancer - Shaping the future dynamics of colorectal cancer management
- Molecular Targeted Cancer Therapies - More drugs on the market, more targets in the pipeline
- Supportive Care in Cancer Treatment - Some first-generation products proving difficult to dislodge
- Pipeline Insight: Insulins - Inhalable insulins unlikely to become blockbusters
- Rheumatoid Arthritis - Biologics battle up the treatment algorithm
- Pipeline Insight: Breast Cancer - A diverse and increasingly crowded pipeline
- Pipeline Insight: Cancer Overview Emerging Therapeutic and Commercial Opportunities
- From Blockbuster to Nichebuster
- Commercial Insight Top 20 Cancer Therapeutics
- Ovarian Cancer: Growing importance as secondary indication for targeted therapies
- Commercial Insight: Transplantation
- Strategies for Biogeneric Success
- Big Pharma' Turns to Biologics for Growth to 2010: Segmentation by drug technology
- Directed Molecular Evolution: Product lifecycle management for biologics
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Rheumatoid Arthritis
- Biotech in Autoimmune and Inflammatory Disease 2006
- Cancer Therapeutics 2006
- Biogenerics
- Cancer Vaccines Measuring Market Potential
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development